Nokia signs video technologies license agreement with Samsung
Press ReleaseNokia signs video technologies license agreement with Samsung License covers the…
Vivoryon Therapeutics N.V. Provides R&D-Update Further Strengthening Development Pipeline in Kidney Disease
Vivoryon Therapeutics N.V. Provides R&D-Update Further Strengthening Development Pipeline in Kidney Disease…
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Teva Pharmaceuticals
CORAL GABLES, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc.…
Nokia reaches 7,000 patent families declared as essential to 5G
Press ReleaseNokia reaches 7,000 patent families declared as essential to 5G Nokia…
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA
Hamilton, Bermuda, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Further proof of great…
Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies
Raanana, Israel, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ)…
Innovative AI Law service to assist the less fortunate in civil rights cases: VRN News
BOSTON, Dec. 29, 2024 (GLOBE NEWSWIRE) -- The more-than-likeness of Google's Willow…
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent
Dallas, TX, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX)…
Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041
COMMACK, NY and TAMPA, FL, Dec. 10, 2024 (GLOBE NEWSWIRE) -- SCIENTURE,…
Recce Pharmaceuticals Granted Australia Patent for RECCE Anti-Infectives
November 27, 2024 08:00 ET | Source: Recce Pharmaceuticals SYDNEY, Nov. 27,…